The agreement signing ceremony for Nanjing Nuoyuan Medical Devices' molecular targeted probe project takes place in Rudong, Nantong. [Photo/WeChat account: rudongfb]

Nanjing Nuoyuan Medical Devices signed an agreement to launch its molecular targeted probe project in the Rudong Economic Development Zone on April 8.

Founded by research teams from Nanjing University and China Pharmaceutical University, Nuoyuan has over 15 years of experience in molecular imaging technology and holds more than 140 invention patents. The newly signed project is a major addition to the company's biomedicine portfolio. It aims to build an international innovation platform, attract academicians, senior experts, and other global talents, and establish facilities such as a joint innovation center for academicians and a postdoctoral research station.

Chen Huiyu, Party secretary of Rudong, said that in recent years Rudong has continued to optimize its policy environment and promote the high-quality development of the biomedicine industry. He expressed hope that the company would leverage its advantages to attract more quality projects and deepen its participation in building Rudong's biomedicine industry cluster.

Cai Huiming, chairman of Nuoyuan, stated that the company will work with Rudong to promote global exchanges and cooperation in the biomedicine field, accelerate scientific and technological innovation, and the commercialization of research outcomes. He added that they aim to develop the Rudong R&D and production base into an internationally competitive innovation hub.